Literature DB >> 28271611

NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy.

Sirpa Loukovaara1, Niina Piippo2,3, Kati Kinnunen4, Maria Hytti2,3, Kai Kaarniranta3,4, Anu Kauppinen2.   

Abstract

PURPOSE: Innate immunity and dysregulation of inflammatory processes play a role in vascular diseases like atherosclerosis or diabetes. Nucleotide-binding domain and Leucine-rich repeat Receptor containing a Pyrin domain 3 (NLRP3) inflammasomes are pro-inflammatory signalling complexes that were found in 2002. In addition to pathogens and other extracellular threats, they can be activated by various endogenous danger signals. The purpose of this study was to find out whether NLRP3 activation occurs in patients with sight-threatening forms of diabetic retinopathy (DR).
METHODS: Inflammasome components NLRP3 and caspase-1, inflammasome-related pro-inflammatory cytokines IL-1β and IL-18, vascular endothelial growth factor (VEGF), acute-phase cytokines TNF-α and IL-6, as well as adaptive immunity-related cytokine interferon gamma (IFN-γ) were measured from the vitreous samples of 15 non-proliferative diabetic retinopathy (non-PDR) and 23 proliferative diabetic retinopathy (PDR) patients using the enzyme-linked immunosorbent assay (ELISA) method. The adaptor protein apoptosis-associated speck-like protein containing a CARD (ASC) was determined using the Western blot technique.
RESULTS: Inflammasome components were present in the vitreous of DR patients. Along with VEGF, the levels of caspase-1 and IL-18 were significantly increased, especially in PDR eyes. Interestingly, clearly higher levels of NLRP3 were found in the PDR eyes with tractional retinal detachment (TRD) than from PDR eyes with fully attached retina. There were no significant differences in the amounts of IL-1β, TNF-α, IL-6, and IFN-γ that were detectable in the vitreous of both non-PDR and PDR patients.
CONCLUSION: Our results suggest that NLRP3 inflammasome activation can be associated especially with the pathogenesis of PDR. The lack of differences in TNF-α, IL-6, and IFN-γ also alludes that acute inflammation or T-cell-mediated responses do not dominate in PDR pathogenesis.
© 2017 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  IL-18; NLRP3; diabetic retinopathy; inflammasome; inflammation; vitrectomy

Mesh:

Substances:

Year:  2017        PMID: 28271611     DOI: 10.1111/aos.13427

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  36 in total

1.  Upregulated CD200 in pre-retinal proliferative fibrovascular membranes of proliferative diabetic retinopathy patients and its correlation with vascular endothelial growth factor.

Authors:  Yaguang Hu; Anming Xie; Qiaochu Cheng
Journal:  Inflamm Res       Date:  2019-10-14       Impact factor: 4.575

2.  Connexin43 hemichannel block protects against the development of diabetic retinopathy signs in a mouse model of the disease.

Authors:  Odunayo O Mugisho; Colin R Green; David M Squirrell; Sarah Bould; Helen V Danesh-Meyer; Jie Zhang; Monica L Acosta; Ilva D Rupenthal
Journal:  J Mol Med (Berl)       Date:  2018-12-08       Impact factor: 4.599

Review 3.  The IL-1β phenomena in neuroinflammatory diseases.

Authors:  Andrew S Mendiola; Astrid E Cardona
Journal:  J Neural Transm (Vienna)       Date:  2017-05-22       Impact factor: 3.575

4.  Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation.

Authors:  Qiuping Liu; Fengjun Zhang; Xian Zhang; Rui Cheng; Jian-Xing Ma; Jinglin Yi; Jingming Li
Journal:  Mol Cell Biochem       Date:  2017-12-21       Impact factor: 3.396

5.  Lysosomal destabilization activates the NLRP3 inflammasome in human umbilical vein endothelial cells (HUVECs).

Authors:  K Kinnunen; N Piippo; S Loukovaara; M Hytti; K Kaarniranta; A Kauppinen
Journal:  J Cell Commun Signal       Date:  2017-05-25       Impact factor: 5.782

Review 6.  Molecules related to diabetic retinopathy in the vitreous and involved pathways.

Authors:  Hua-Qin Xia; Jia-Rui Yang; Ke-Xin Zhang; Rui-Lan Dong; Hao Yuan; Yu-Chen Wang; Hong Zhou; Xue-Min Li
Journal:  Int J Ophthalmol       Date:  2022-07-18       Impact factor: 1.645

Review 7.  Changes in aqueous and vitreous inflammatory cytokine levels in proliferative diabetic retinopathy: a systematic review and meta-analysis.

Authors:  Ryan H Mason; Samuel A Minaker; Gabriela Lahaie Luna; Priya Bapat; Armin Farahvash; Anubhav Garg; Nishaant Bhambra; Rajeev H Muni
Journal:  Eye (Lond)       Date:  2022-06-07       Impact factor: 4.456

8.  Diet-induced obesity leads to pro-inflammatory alterations to the vitreous humour of the eye in a rat model.

Authors:  Kelsey H Collins; Walter Herzog; Raylene A Reimer; Carol R Reno; Bryan J Heard; David A Hart
Journal:  Inflamm Res       Date:  2017-10-26       Impact factor: 4.575

9.  NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia.

Authors:  Rebecca Ward; Weiguo Li; Yasir Abdul; LaDonya Jackson; Guangkuo Dong; Sarah Jamil; Jessica Filosa; Susan C Fagan; Adviye Ergul
Journal:  Pharmacol Res       Date:  2019-02-25       Impact factor: 7.658

10.  Protective role and molecular mechanism of action of Nesfatin-1 against high glucose-induced inflammation, oxidative stress and apoptosis in retinal epithelial cells.

Authors:  Haiyan Sun; Huahui Zhao; Zhipeng Yan; Xiaokun Liu; Pengfei Yin; Jun Zhang
Journal:  Exp Ther Med       Date:  2021-06-03       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.